For more information or confidential assistance
Call 800-306-3180

New Hampshire Couple Files Federal Actos Lawsuit

William and May Youngclaus of New Hampshire are the plaintiffs in a federal lawsuit claiming Mr. Youngclaus’ bladder cancer was an Actos side effect. The case is part of the multidistrict litigation in the Western District of Louisiana against the makers of Actos, Takeda Pharmaceuticals... Read More

Actos and Bladder Cancer Link Alleged by Plaintiffs

Pharmaceutical companies are required to fully disclose the risks and side effects of their medications. When they fail to do so, patients often suffer catastrophic consequences. Many diabetes patients have filed complaints against Takeda Pharmaceuticals, alleging that its drug, Actos (pioglitazone hydrochloride) is unreasonably dangerous... Read More

Takeda Faces Another Actos Cancer Lawsuit

Actos lawsuit news
A man has begun legal proceedings against Takeda after their diabetes drug Actos allegedly caused his bladder cancer. The lawsuit was filed in the Circuit Court of Cook County, Illinois, and is to be consolidated with related cases. According to the lawsuit, the plaintiff was... Read More

Actos Lawsuit News: MDL 2299 Gains New Bundled Complaint

In Actos lawsuit news, Takeda Pharmaceuticals continues to defend claims that it failed to warn consumers that its flagship type 2 diabetes medication causes a disproportionately high risk for developing bladder cancer. A bundled complaint filed by fourteen plaintiffs recently joined the Actos products liability... Read More

Actos Lawsuit Trial Underway in Maryland

gavel and scale of justice
Takeda Pharmaceuticals failed to warn patients about increased Actos bladder cancer risks, an attorney argued in state court in Baltimore earlier this month. This Actos lawsuit trial is one of more than 3,000 cases against the pharmaceutical company over the diabetes drug, according to Bloomberg.... Read More